NovaBone Adds New Biologically-active Bone Graft Substitutes

NovaBone Products launched NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically-active bone graft substitutes.

Both formulations are designed to optimize osteogenesis, stimulate osteoblastic activity and offer angiogenic potential. The products are highly resistant to irrigation and designed with high-performing cohesion and...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0